antibody-based diagnostics

Jun 3, 2022

Hong Kong-Based Team Develops Rapid Microfluidic SARS-CoV-2 Antibody Test
Premium

May 26, 2022

Euroimmun to Distribute GenScript Serology COVID-19 Test in US, Canada

May 13, 2022

MIP Diagnostics Sees COVID-19 Molecularly Imprinted Polymers as 'Showcase' for Company's Future
Premium

Apr 13, 2022

Pictor Obtains $6.1M Investment to Market SARS-CoV-2 Antibody Test

Mar 23, 2022

Diadem to Launch Alzheimer's Screening Assay This Year While Developing Confirmatory Test
Premium

Mar 15, 2022

LuSys Laboratories Recalls COVID-19 Antigen, Antibody Tests at FDA's Request

Mar 11, 2022

Grip Molecular Developing Biosensor Panel to Detect SARS-CoV-2, Other Respiratory Infections
Premium

Mar 7, 2022

Diadem Obtains €7.5M Loan for Development, Commercialization of Alzheimer's Disease Blood Test

Mar 4, 2022

Immucor Obtains FDA Clearance for Single-Antigen Assays to Identify Donors for Transplants

Mar 4, 2022

New York State Grants Conditional Approval to KSL Diagnostics for COVID-19 Antibody Assay

Feb 14, 2022

Attana, Capitainer Collaborate on COVID-19 Immune Profile Testing

Feb 1, 2022

Abcam to License Phage Library from Twist Bioscience for Antibody Discovery, Diagnostics

Jan 28, 2022

Empowered Diagnostics Recalls COVID-19 Antigen Test at FDA's Request

Jan 6, 2022

As Third Year of Pandemic Approaches, Role of SARS-CoV-2 Serology Tests Remains Opaque
Premium

Nov 24, 2021

WHO Inks License Agreement for Commercialization, Manufacturing of COVID-19 Antibody Test Technology

Nov 1, 2021

GS Labs Sues Insurer Medica for COVID-19 Rapid Test Reimbursement

Oct 22, 2021

Newly Nonprofit Mologic Accelerates Work on Neglected Disease Tests, Affordable COVID-19 Assays
Premium

Oct 7, 2021

Post-IPO, LumiraDx Pushes Adoption of POC Instrument, Eyes Test Menu Expansion
Premium

Oct 5, 2021

Euroimmun COVID-19 Antibody Test Gets FDA Emergency Use Authorization

Sep 29, 2021

Point-of-Care Test Developer LumiraDx Goes Public on Nasdaq